Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin. Europace 2016;18:979-86. PUBMED | CROSSREFReddy VY, Akehurst RL, Armstrong SO, et al. Cost effectiveness of left atrial appendage closure with ...
Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Se... BACKGROUND AND PURPOSE: Once a patient with atrial fibrillation experiences an embolic event, the risk of a recurrent event increases 2.6-fold...
Both NOACs and LAAC with the Watchman device were cost-effective relative to warfarin, but LAAC was also found to be cost-effective and to offer better value relative to NOACs. The results of this analysis should be considered when formulating policy and practice guidelines for stroke preventio...
Stroke: A Journal of Cerebral CirculationReddy VY, Akehurst RL, Amorosi SL, Gavaghan MB, Hertz DS, Holmes DR Jr. Cost-effectiveness of left atrial appendage clo- sure with the Watchman device compared with warfarin or non- vitamin K antagonist oral anticoagulants for secondary prevention in non...
Stroke: A Journal of Cerebral CirculationReddy VY, Akehurst RL, Amorosi SL, Gavaghan MB, Hertz DS, Holmes DR Jr. Cost-effectiveness of left atrial appendage clo- sure with the Watchman device compared with warfarin or non- vitamin K antagonist oral anticoagulants for secondary prevention in non...
Cost effec- tiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contra- indications to warfarin [published online ahead of print February 2, 2016]. Europace. 2016;pii: euv412.V.Y. Reddy, R.L. Akehurst, S.O. Armstrong, S.L. ...
Background Left atrial appendage occlusion (LAAO) using Watchman device has become a world-wide, well-established therapeutic alternative to chronic systemic oral anticoagulation in patient who are at high-risk of bleeding with paroxysmal (PAF) or chronic atrial fibrillation (Afib). Currently, LAAO...
This study was performed to compare the clinical effectiveness and safety of reduced rivaroxaban dose (RRD) and dual antiplatelet therapy (DAPT) after left atrial appendage closure (LAAC) implantation with the Watchman device. Methods: After successful LAAC, consecutive participants were...
Background-Randomized trials of left atrial appendage (LAA) closure with the Watchman device have shown varying results, and its cost effectiveness compared with anticoagulation has not been evaluated using all available contemporary trial data.Freeman, James V.Hutton, David W.Barnes, Geoffrey D.Zhu...